Reconnect Foundation

Reconnect Foundation is a Swiss non-profit organization dedicated to the research and development of psychedelic-assisted therapies for mental health disorders. Based in Zurich, the foundation supports clinical trials and neuroscientific research into substances such as psilocybin and LSD, primarily targeting conditions like depression and addiction. It operates in close collaboration with the University of Zurich and the University Hospital of Psychiatry Zurich to bridge the gap between academic research and clinical application. The foundation's mission is to establish safe, evidence-based protocols for the therapeutic use of psychedelics within the modern healthcare system. By funding rigorous scientific studies, Reconnect Foundation aims to provide new treatment options for patients who do not respond to conventional psychiatric medications. Their work is instrumental in advancing the scientific understanding of how psychedelics affect the human brain and behavior.